LT2981271T - Empagliflozino terapinis panaudojimas - Google Patents
Empagliflozino terapinis panaudojimasInfo
- Publication number
- LT2981271T LT2981271T LTEP14715578.2T LT14715578T LT2981271T LT 2981271 T LT2981271 T LT 2981271T LT 14715578 T LT14715578 T LT 14715578T LT 2981271 T LT2981271 T LT 2981271T
- Authority
- LT
- Lithuania
- Prior art keywords
- empagliflozin
- therapeutic uses
- therapeutic
- Prior art date
Links
- OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 title 1
- 229960003345 empagliflozin Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361808804P | 2013-04-05 | 2013-04-05 | |
| CA2812519A CA2812519A1 (en) | 2013-04-05 | 2013-04-10 | Pharmaceutical composition, methods for treating and uses thereof |
| US201361908991P | 2013-11-26 | 2013-11-26 | |
| PCT/EP2014/056657 WO2014161919A1 (en) | 2013-04-05 | 2014-04-03 | Therapeutic uses of empagliflozin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2981271T true LT2981271T (lt) | 2019-01-10 |
Family
ID=51787230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP14715578.2T LT2981271T (lt) | 2013-04-05 | 2014-04-03 | Empagliflozino terapinis panaudojimas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240066046A1 (lt) |
| EP (2) | EP3456332A1 (lt) |
| JP (1) | JP6177992B2 (lt) |
| KR (3) | KR20230125858A (lt) |
| CN (2) | CN109893534A (lt) |
| AU (1) | AU2014247092B2 (lt) |
| CA (3) | CA2812519A1 (lt) |
| DK (1) | DK2981271T3 (lt) |
| EA (1) | EA033397B1 (lt) |
| LT (1) | LT2981271T (lt) |
| MX (2) | MX2015013939A (lt) |
| PL (1) | PL2981271T3 (lt) |
| RS (1) | RS58097B1 (lt) |
| SI (1) | SI2981271T1 (lt) |
| WO (1) | WO2014161919A1 (lt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| ES2702174T3 (es) | 2013-04-05 | 2019-02-27 | Boehringer Ingelheim Int | Usos terapéuticos de empagliflozina |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| KR102309654B1 (ko) | 2013-04-18 | 2021-10-08 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| CN105769782A (zh) * | 2014-12-23 | 2016-07-20 | 中美华世通生物医药科技（武汉）有限公司 | 恩格列净片及其制备方法和用途 |
| CN106880595A (zh) * | 2015-12-10 | 2017-06-23 | 常州方楠医药技术有限公司 | 一种无定型依帕列净的固体分散体及其制备方法 |
| CN109922813A (zh) * | 2016-11-10 | 2019-06-21 | 勃林格殷格翰国际有限公司 | 药物组合物、治疗方法及其用途 |
| KR20200102982A (ko) | 2017-10-02 | 2020-09-01 | 폭셀 | 보존된 박출률을 갖는 심부전의 치료 방법 |
| AU2019278017A1 (en) | 2018-05-31 | 2021-01-21 | Hua Medicine (Shanghai) Ltd. | Pharmaceutical combination, composition and formulation containing glucokinase activator and alpha-glucosidase inhibitor, preparation methods therefor and uses thereof |
| BR112020024643A2 (pt) | 2018-06-06 | 2021-03-02 | Metavant Sciences Gmbh | método de tratamento de pré-diabetes ou diabetes mellitus tipo 1 ou tipo 2, método de melhoria do controle glicêmico em um sujeito tendo pré-diabetes ou diabetes tipo 1 ou tipo 2, imeglimina para uso em um método para tratamento de pré-diabetes ou diabetes mellitus tipo 1 ou tipo 2 de um sujeito, imeglimina para uso em um método para melhoria do controle glicêmico em um sujeito tendo pré-diabetes ou diabetes tipo 1 ou tipo 2, uso de imeglimina para a fabricação de um medicamento para o tratamento de um sujeito tendo pré-diabetes ou diabetes mellitus tipo 1 ou tipo 2 e uso de imeglimina para a fabricação de um medicamento para melhoria do controle glicêmico em um sujeito tendo pré-diabetes ou diabetes tipo 1 ou tipo 2 |
| BR112020025112A2 (pt) | 2018-06-14 | 2021-03-23 | Poxel | comprimido revestido por película e processo para a fabricação do comprimido revestido por película |
| CN110141555A (zh) * | 2019-06-21 | 2019-08-20 | 江苏豪森药业集团有限公司 | 一种恩格列净片及其制备方法 |
| CN110721170A (zh) * | 2019-10-24 | 2020-01-24 | 安徽九华华源药业有限公司 | 一种恩格列净片剂及其制备方法 |
| WO2022065895A1 (ko) * | 2020-09-24 | 2022-03-31 | 동아에스티 주식회사 | Sglt-2 억제제인 엠파글리플로진 유도체의 신규염 및 염의 수화물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000219632A (ja) * | 1999-01-28 | 2000-08-08 | Toyotama Koryo Kk | カロリー軽減剤 |
| DE102004012676A1 (de) * | 2004-03-16 | 2005-10-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Glucopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| JP2006176443A (ja) * | 2004-12-22 | 2006-07-06 | Shionogi & Co Ltd | メラニン凝集ホルモン受容体アンタゴニスト |
| UA91546C2 (uk) | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
| WO2008055940A2 (en) * | 2006-11-09 | 2008-05-15 | Boehringer Ingelheim International Gmbh | Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions |
| JP2010524944A (ja) * | 2007-04-20 | 2010-07-22 | シェーリング コーポレイション | テトラヒドロピリド［４，３−ｄ］ピリミジノン誘導体およびそれらの使用方法 |
| PE20090938A1 (es) | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
| US20110015225A1 (en) * | 2008-04-01 | 2011-01-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| SG173587A1 (en) * | 2009-02-13 | 2011-09-29 | Boehringer Ingelheim Int | Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia |
| KR101921934B1 (ko) * | 2009-02-13 | 2018-11-26 | 베링거 인겔하임 인터내셔날 게엠베하 | 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도 |
| US10610489B2 (en) * | 2009-10-02 | 2020-04-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| US20130035298A1 (en) | 2011-07-08 | 2013-02-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
-
2013
- 2013-04-10 CA CA2812519A patent/CA2812519A1/en not_active Abandoned
-
2014
- 2014-04-03 KR KR1020237028350A patent/KR20230125858A/ko not_active Application Discontinuation
- 2014-04-03 EP EP18197967.5A patent/EP3456332A1/en not_active Withdrawn
- 2014-04-03 JP JP2016505816A patent/JP6177992B2/ja active Active
- 2014-04-03 EP EP14715578.2A patent/EP2981271B1/en active Active
- 2014-04-03 MX MX2015013939A patent/MX2015013939A/es active IP Right Grant
- 2014-04-03 KR KR1020157031845A patent/KR102318213B1/ko active IP Right Review Request
- 2014-04-03 AU AU2014247092A patent/AU2014247092B2/en active Active
- 2014-04-03 KR KR1020217034101A patent/KR20210130844A/ko active Application Filing
- 2014-04-03 CA CA3121761A patent/CA3121761A1/en active Pending
- 2014-04-03 RS RS20181558A patent/RS58097B1/sr unknown
- 2014-04-03 SI SI201431030T patent/SI2981271T1/sl unknown
- 2014-04-03 CN CN201910175299.7A patent/CN109893534A/zh active Pending
- 2014-04-03 EA EA201500997A patent/EA033397B1/ru not_active IP Right Cessation
- 2014-04-03 CN CN201480031563.5A patent/CN105377267A/zh active Pending
- 2014-04-03 PL PL14715578T patent/PL2981271T3/pl unknown
- 2014-04-03 LT LTEP14715578.2T patent/LT2981271T/lt unknown
- 2014-04-03 DK DK14715578.2T patent/DK2981271T3/en active
- 2014-04-03 WO PCT/EP2014/056657 patent/WO2014161919A1/en active Application Filing
- 2014-04-03 CA CA2908635A patent/CA2908635C/en active Active
-
2015
- 2015-10-01 MX MX2020010004A patent/MX2020010004A/es unknown
-
2023
- 2023-10-24 US US18/492,972 patent/US20240066046A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2812519A1 (en) | 2014-10-05 |
| PL2981271T3 (pl) | 2019-05-31 |
| US20240066046A1 (en) | 2024-02-29 |
| EA033397B1 (ru) | 2019-10-31 |
| EP3456332A1 (en) | 2019-03-20 |
| CN109893534A (zh) | 2019-06-18 |
| EP2981271B1 (en) | 2018-11-14 |
| DK2981271T3 (en) | 2019-02-04 |
| CA3121761A1 (en) | 2014-10-09 |
| CA2908635C (en) | 2021-07-13 |
| RS58097B1 (sr) | 2019-02-28 |
| MX2020010004A (es) | 2020-10-14 |
| JP6177992B2 (ja) | 2017-08-09 |
| KR20230125858A (ko) | 2023-08-29 |
| KR20150138860A (ko) | 2015-12-10 |
| KR102318213B1 (ko) | 2021-10-28 |
| AU2014247092B2 (en) | 2018-11-01 |
| EA201500997A1 (ru) | 2016-04-29 |
| MX2015013939A (es) | 2016-07-20 |
| EP2981271A1 (en) | 2016-02-10 |
| SI2981271T1 (sl) | 2019-02-28 |
| CN105377267A (zh) | 2016-03-02 |
| KR20210130844A (ko) | 2021-11-01 |
| WO2014161919A1 (en) | 2014-10-09 |
| CA2908635A1 (en) | 2014-10-09 |
| JP2016515600A (ja) | 2016-05-30 |
| AU2014247092A1 (en) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287516A (en) | Medicinal uses of empagliflozin | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| HK1213818A1 (zh) | 依帕列淨的治療用途 | |
| HK1254296A1 (zh) | 治療性化合物和其用途 | |
| PL2981271T3 (pl) | Zastosowania terapeutyczne empagliflozyny | |
| HRP20181710T1 (hr) | Uporaba derivata benzimidazol-prolina | |
| HK1217092A1 (zh) | 治療性化合物及其用途 | |
| GB201308440D0 (en) | Therapeutic | |
| GB201310755D0 (en) | Therapy | |
| HK1188366A2 (en) | One type of massager | |
| GB201318668D0 (en) | Sonosensitive therapeutic | |
| HK1204916A1 (en) | Pharmaceutical application of anhydroicaritin | |
| PL2948129T3 (pl) | Związki terapeutyczne | |
| GB201314286D0 (en) | Therapeutic Compounds | |
| GB201312499D0 (en) | Therapeutic compounds | |
| GB201320905D0 (en) | Therapeutic compounds | |
| HK1198422A1 (en) | Novel uses of colossolactones | |
| PL3071575T3 (pl) | Wytwarzanie normorfinanów | |
| EP2996684A4 (en) | THERAPEUTIC PROCEDURES | |
| TWM475821U (en) | Structure of mosquito-catch | |
| TWM475524U (en) | Structure of rivet-pulling | |
| GB201304608D0 (en) | BenTime of Yisrael operable arrangement | |
| GB201309967D0 (en) | Therapeutic combinations | |
| GB201320349D0 (en) | New therapeutic use | |
| GB201314397D0 (en) | Therapeutic Compounds |